Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Costs of PGT-A

Course / Costs of PGT-A

What Does PGT-A Cost?

The cost of PGT-A varies depending on the fertility clinic, laboratory, and the number of embryos tested.
In the United States, most patients can expect to spend between $4,000 and $7,000 for a typical IVF cycle that includes PGT-A.

The breakdown often includes:

  • Embryo biopsy fees: Charged by the IVF clinic for cell removal and preparation (usually $500–$1,500).

  • Genetic testing fees: Charged by the laboratory performing chromosomal analysis (usually $250–$400 per embryo).

  • Embryo freezing and storage: Additional costs apply for cryopreservation while awaiting test results.

It’s important to note that these costs are typically not covered by insurance, although some states and employers offer partial coverage for IVF-related genetic testing.

Components of Cost

PGT-A expenses can be grouped into three main categories:

  1. Clinical Procedure Costs

    • Embryo biopsy requires advanced laboratory equipment and highly trained embryologists.

    • Clinics that maintain in-house biopsy services often charge higher fees but offer faster turnaround and tighter quality control.

  2. Laboratory Testing Costs

    • Genetic testing is usually outsourced to specialized labs that perform next-generation sequencing (NGS) or array-based analysis.

    • Each embryo incurs an individual charge, which can add up when multiple embryos are tested.

  3. Ancillary Services

    • Embryo freezing, storage, and transfer cycles all contribute to total costs.

    • In some cases, embryos must be shipped to third-party labs, adding logistics fees.

Clinics offering “PGT-A package pricing” may bundle these expenses, but patients should always confirm what the package includes and whether retesting or re-biopsy costs extra.

Questions of Value

The central question for most intended parents and clinics is whether PGT-A is worth the investment.
From a clinical standpoint, value depends on three key factors:

  1. Age and Embryo Quality

    • Older patients (typically over 38) face higher rates of aneuploidy, making PGT-A more useful in identifying viable embryos.

    • Younger patients with a large number of high-quality embryos may see less incremental value.

  2. Reproductive Goals

    • For patients seeking a single, healthy pregnancy, PGT-A may reduce miscarriage risk and optimize transfer decisions.

    • For those pursuing multiple children or embryo banking, the upfront cost could pay off by minimizing failed transfers.

  3. Laboratory Expertise and Accuracy

    • The value of PGT-A is directly linked to testing precision and lab reliability.

    • False positives or misinterpretation can undermine both the financial and emotional investment.

In short, PGT-A delivers the greatest value when applied strategically—based on age, clinical history, and the number of embryos available for testing.

Cost Consideration Example: Younger Patient Scenario

Let’s consider a younger intended parent (early 30s) who produces six viable embryos after IVF.
If three of these embryos test as chromosomally normal (euploid), the patient might only transfer one embryo per cycle, reducing the chance of multiple pregnancies and lowering the risk of miscarriage.

Although PGT-A adds cost upfront, it can reduce the total number of transfer cycles needed, which in turn may offset the financial investment through higher efficiency and fewer failed attempts.

Cost Consideration Example: Older Patient Scenario

Now consider a patient in her early 40s who produces four embryos, none of which are euploid.
While this outcome can be emotionally and financially challenging, it provides valuable information before transfer—avoiding the cost, time, and emotional toll of failed implantations or miscarriages.

In such cases, PGT-A may ultimately prevent unnecessary transfer cycles and guide future IVF strategies, such as using donor eggs or optimizing stimulation protocols.

Pro Tips from Fertility Experts

  1. Ask for a full cost breakdown. Ensure the quoted PGT-A price includes biopsy, testing, and freezing.

  2. Evaluate testing need by age and embryo count. The test may not add value for younger patients with few embryos.

  3. Select a reputable testing lab. Accuracy and reporting quality directly influence the test’s usefulness.

  4. Plan financially in advance. Include PGT-A in your IVF budgeting to avoid unexpected costs mid-cycle.

  5. Seek individualized recommendations. Fertility decisions should be guided by medical indicators, not marketing promises.